Two of a kind: mass and molar immunoassay-based lipoprotein (a) concentrations are similarly prognostic for MACE risk and predictive of alirocumab benefit in ODYSSEY OUTCOMES
25 August 2023 (07:30 - 18:30)
Organised by: 

About the speaker

Hospital Bichat-Claude Bernard, Paris (France)
6 More presentations in this session
Professor C. Pemberton (Christchurch, NZ)
Doctor A. Alatta (Newcastle-Upon-Tyne, GB)
Doctor J. Knott (Rochester, US)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023
You may be interested in
Congress Presentation
